Vsquared Ventures

Vsquared Ventures invests in early‑stage deep‑tech companies that address society’s most pressing challenges. Its focus areas include quantum and novel computing, green energy, robotics, AI/ML, new space, synthetic biology, and healthcare. The firm partners closely with its portfolio companies to accelerate and scale their visions, unlocking possibilities that might otherwise seem impossible.

Herbert Mangesius

General Partner

Maximilian Odendahl

Venture Partner

Tommy Oehl

General Partner

Patrick Tucci

Associate

Ferdinand Vermersch

Associate

Benedikt Von Schoeler

General Partner

Past deals in Barcelona

Inbrain Neuroelectronics

Series B in 2024
Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.

Inbrain Neuroelectronics

Series A in 2021
Inbrain Neuroelectronics is a medical device company that designs and commercializes graphene-based neural interfaces and intelligent neuromodulation systems to treat brain disorders. The core platform is an implantable system that decodes brain activity with high resolution and provides focal, adaptive stimulation, enabling real-time precision neurology and autonomous therapy adjustments. This approach aims to maximize therapeutic outcomes while minimizing side effects for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. The company pursues strategic collaborations to extend its solutions to peripheral nerve and systemic disease applications, expanding the potential of neurotechnology and bioelectronics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.